In a 30-year-old woman with a 2 cm endometrial polyp identified on ultrasound and a normal menstrual cycle, what further management should be undertaken?

Hysteroscopic Polypectomy is Recommended

For a 30-year-old woman with a 2 cm endometrial polyp and normal menstrual cycles, hysteroscopic polypectomy should be performed, preferably in an outpatient setting using mechanical tissue removal systems. 1

Rationale for Intervention

Despite the absence of abnormal bleeding, several factors support active management in this case:

Size Threshold

• The 2 cm diameter exceeds the conservative management threshold. Polyps <10 mm may regress spontaneously in up to 25% of cases 2, 3, but larger polyps (>2 cm) warrant removal even in asymptomatic patients 4
• Larger polyps have lower spontaneous regression rates and higher intervention rates 5

Age and Fertility Considerations

• At 30 years old, this patient is in her reproductive years where polyps can impact future fertility
• Hysteroscopic polypectomy before attempting conception improves pregnancy rates, with relative risk of 2.1 (95% CI 1.5-2.9) for successful pregnancy 6
• Clinical pregnancy rates after polypectomy range from 53-72% in fertility contexts 6
• Even without current fertility plans, preserving reproductive potential is important at this age

Histopathological Assessment

• Histological examination is mandatory to exclude malignancy 4, though risk is low in premenopausal women without bleeding
• The overall malignancy risk in polyps is approximately 3% 3, but increases with age

Recommended Surgical Approach

Outpatient Hysteroscopic Polypectomy

The procedure should be performed in an outpatient setting using the following protocol 1:

• Vaginoscopic approach (no speculum) to minimize pain 1
• Mechanical hysteroscopic tissue removal (mHTR) systems (e.g., Truclear) rather than bipolar electrodes - these are less painful, quicker, more successful, and better tolerated 1
• Smallest diameter hysteroscope possible, ideally with expandable outer working channels 1
• Pre-procedure oral NSAIDs one hour before the appointment 1

Pain Management Strategy

• Standard oral NSAIDs pre-procedure 1
• Local anesthesia is NOT routinely needed with vaginoscopic approach 1
• Consider local anesthesia only if cervical dilation or larger hysteroscopes (≥5mm) are required 1
• Conscious sedation should NOT be routinely used 1

Common Pitfalls to Avoid

Do NOT Perform Blind D&C

Blind dilatation and curettage is contraindicated 4, 7, 8 - it has poor diagnostic accuracy for focal endometrial pathology and inadequate polyp removal rates

Ensure Complete Removal

• Incomplete resection is a major risk factor for recurrence 9
• Hysteroscopic visualization ensures complete excision and reduces recurrence risk

Patient Counseling Points

• Provide written information about the procedure, benefits, risks, and alternatives before the appointment 1
• Inform patient they can stop the procedure at any time if experiencing excessive pain 1
• Discuss alternative settings (general anesthesia) if outpatient approach fails 1

Alternative: Expectant Management (Not Recommended Here)

While expectant management is an option for small asymptomatic polyps, it is not appropriate in this case because:

• The 2 cm size exceeds conservative management criteria 4
• Spontaneous regression is unlikely (only 8% overall, 14.5% in premenopausal women) 5
• The patient's reproductive age favors intervention to preserve fertility potential
• Larger polyps and higher vascularity predict earlier need for intervention 5

Post-Procedure Considerations

• Histopathological examination of all removed tissue is mandatory 4, 8
• Consider hormonal therapy (progesterone or LNG-IUS) post-polypectomy if recurrence risk factors present (obesity, metabolic syndrome) 9
• Hysteroscopic polypectomy has negligible risk of intrauterine adhesion formation 4